Why Celgene Sank to New Low Despite Q3 Earnings Beat
Despite mixed results, with earnings were fairly positive for the quarter, this was not enough to outweigh poor guidance. Shares sank to a new 52-week low.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 154
Short Sellers Chase Biotechs Higher
The October 13 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Short Sellers Hike Bets in Major Pharma
The October 13 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Jefferies Has Top Health Care Stocks to Buy as Sector Explodes
These are four top companies for more aggressive investors looking for health care exposure to consider.
The Tale of 2 Biotechs: Aimmune vs DBV Tech
The tale of two biotechs appears to be playing out between Aimmune Therapeutics and DBV Technologies, not just for the companies but between analysts as well.
Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week
At least eight large biotech and pharma outfits are scheduled to report their latest earnings and revenues this coming week.
Polluted Air, Water Cost 9 Million Lives in 1 Year
In 2015, 9 million people died prematurely as a result of pollution. That's 16% of all human deaths worldwide for the year. A new study looks at what can be done.
Does Gilead’s CAR T Approval Vindicate the High Acquisition Price for Kite Pharma?
Now there is a new FDA approval Gilead's CAR T lymphoma treatment named Yescarta that has created at least some buzz for Gilead.
4 Large Cap Pharmaceutical Stocks That Could Post Big Earnings
These four top companies all have data that could move the shares the rest of this year and into 2018. All have been around for years and will remain sector leaders for years to…
Will Eli Lilly’s mRNA Cancer Vaccine Investment Hit Paydirt?
With Eli Lilly making a huge headline investment in a cancer vaccine, 24/7 Wall St. wanted to look under the hood to see what this deal really entails.
Analysts Piling On to Raise Johnson & Johnson Price Targets Higher and Higher
24/7 Wall St. tracks key analyst calls in the stocks that move the markets and which are important to investors. It has been almost amazing to see just how many price targets have been…
Why Spectrum Pharmaceuticals Shares Are Surging
Spectrum Pharmaceuticals saw its shares make a solid gain early on Wednesday after the firm announced interim data from its mid-stage trial for the treatment of non-small cell lung cancer.
UnitedHealth Profits Jump, Raises EPS Estimate
UnitedHealth Group beat EPS and revenue estimates for the third quarter despite a sharp hit related to withdrawing from the ACA program.
Johnson & Johnson Pharmaceutical, Domestic Sales Fuel Growth
Johnson & Johnson reported better-than-expected fiscal third-quarter financial results before the markets opened on Tuesday.
Exelixis Cancer Treatment Hits Key Milestone
Exelixis kicked off the week with a couple updates that are already having a big impact on the stock. These updates came in the form of a key FDA approval.